Non-muscle invasive bladder cancer tends to recur after transurethral resection (TUR) and an intravesical adjuvant chemotherapy or immunotherapy is usually needed to decrease the recurrence rate, or sometimes progression. Instillations can be applied immediately after TUR and then in scheduled basis. © Springer-Verlag London 2017
Introduction: Transurethral resection of the bladder tumour (TURBT) is still the standard initial tr...
Contains fulltext : 70664.pdf (publisher's version ) (Closed access)OBJECTIVES: In...
We evaluated the efficacy of single-dose instillation of pirarubicine hydrochloride (THP) in the che...
Urinary bladder cancer is a relatively common condition. A significant proportion of intermediate an...
Non-muscle-invasive bladder cancer (NMIBC) is characterized by a tendency for recurrence and capacit...
Bladder cancer is the second most common tumor among all neoplasms of the genitourinary tract in the...
Intravesical chemotherapy is performed after transurethral resection (TUR) of bladder tumors for red...
<p><strong>Objective:</strong> to enhance the efficiency of combined treatment for non-muscle-invasi...
Background Immediate intravesical instillation of chemotherapeutic agents after transurethral resect...
Objectives: Intravesical chemotherapy has been studied in randomized clinical trials for >30 yr; how...
Objectives: Intravesical chemotherapy has been studied in randomized clinical trials for >30 yr; how...
ABSTRACT Introduction and Objective: Adjuvant intravesical chemotherapy or BCG immunotherapy aft...
We retrospectively evaluated the efficacy of immediate single instillation (SI) of pirarubicine hydr...
Transurethral resection (TUR) of the superficial transitional cell carcinoma (TCC) of the bladder is...
OBJECTIVE To evaluate the efficacy of 1-year maintenance after a 6-week cycle of early intravesical ...
Introduction: Transurethral resection of the bladder tumour (TURBT) is still the standard initial tr...
Contains fulltext : 70664.pdf (publisher's version ) (Closed access)OBJECTIVES: In...
We evaluated the efficacy of single-dose instillation of pirarubicine hydrochloride (THP) in the che...
Urinary bladder cancer is a relatively common condition. A significant proportion of intermediate an...
Non-muscle-invasive bladder cancer (NMIBC) is characterized by a tendency for recurrence and capacit...
Bladder cancer is the second most common tumor among all neoplasms of the genitourinary tract in the...
Intravesical chemotherapy is performed after transurethral resection (TUR) of bladder tumors for red...
<p><strong>Objective:</strong> to enhance the efficiency of combined treatment for non-muscle-invasi...
Background Immediate intravesical instillation of chemotherapeutic agents after transurethral resect...
Objectives: Intravesical chemotherapy has been studied in randomized clinical trials for >30 yr; how...
Objectives: Intravesical chemotherapy has been studied in randomized clinical trials for >30 yr; how...
ABSTRACT Introduction and Objective: Adjuvant intravesical chemotherapy or BCG immunotherapy aft...
We retrospectively evaluated the efficacy of immediate single instillation (SI) of pirarubicine hydr...
Transurethral resection (TUR) of the superficial transitional cell carcinoma (TCC) of the bladder is...
OBJECTIVE To evaluate the efficacy of 1-year maintenance after a 6-week cycle of early intravesical ...
Introduction: Transurethral resection of the bladder tumour (TURBT) is still the standard initial tr...
Contains fulltext : 70664.pdf (publisher's version ) (Closed access)OBJECTIVES: In...
We evaluated the efficacy of single-dose instillation of pirarubicine hydrochloride (THP) in the che...
DOI
Add to ORKG